UNLIMITED TURBO LONG - CARL ZEISS MEDITEC Stock

Certificat

DE000PZ6M5Z5

Market Closed - Deutsche Boerse AG 03:20:18 2024-05-17 pm EDT
2.87 EUR -5.28% Intraday chart for UNLIMITED TURBO LONG - CARL ZEISS MEDITEC
Current month-12.50%
1 month-4.65%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-17 2.87 -5.28%
24-05-16 3.03 +3.41%
24-05-15 2.93 -1.35%
24-05-14 2.97 +12.08%
24-05-13 2.65 -6.36%

Delayed Quote Deutsche Boerse AG

Last update May 17, 2024 at 03:20 pm EDT

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying CARL ZEISS MEDITEC AG
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PZ6M5Z
ISINDE000PZ6M5Z5
Date issued 2019-02-18
Strike 66.95
Maturity Unlimited
Parity 10 : 1
Emission price 2.17
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 14.19
Lowest since issue 0.87

Company Profile

Carl Zeiss Meditec AG is a Germany-based medical technology and device company. It offers offers complete solutions to diagnose and treat ophtalmic diseases, visualization solutions for microsurgery and other technologies, such as intraoperative radiotherapy. The Company operates in two segments: Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment comprises activities in the area of ophthalmology, such as intraocular lenses, surgical visualization solutions and medical laser and diagnostic systems. The Microsurgery segment includes activities of neuro, ear, nose and throat surgery, as well as the activities in the field of intraoperative radiation. The Company has various production sites in Europe, the United States and Asia.
Sector
-
More about the company

Ratings for Carl Zeiss Meditec AG

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: Carl Zeiss Meditec AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
15
Last Close Price
95.3 EUR
Average target price
105.5 EUR
Spread / Average Target
+10.74%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW